Literature DB >> 2549102

In vitro amplification of hepatitis B virus sequences from liver tumour DNA and from paraffin wax embedded tissues using the polymerase chain reaction.

Y M Lo1, W Z Mehal, K A Fleming.   

Abstract

A 185 base pair fragment from the core-polymerase overlap region of the hepatitis B virus (HBV) genome was amplified using the polymerase chain reaction (PCR). The results were compared with those of Southern blotting on extracted DNA from eight hepatocellular carcinomata. The data agreed with those of Southern blotting in six cases (two positive, four negative) but in two other positive cases PCR failed to amplify HBV sequences. This suggests deletion or mutation, or both, of this viral region in these cases. PCR was also used to amplify HBV sequences from formalin fixed, paraffin wax embedded tissue. Tissue inhibition of PCR occurred which increased with the number of tissue sections. It was present in tissues from different organs and species and fixed by different procedures, thus highlighting the need for a positive control during amplification. Use of formalin fixed Alexander cells, however, showed a sensitivity of one viral copy per 5000 cells. Confirmation of the identity of the PCR products was carried out using PCR-generated biotinylated probes, and suggested the insertion of extra nucleotide sequences or infection with an HBV variant in one case.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549102      PMCID: PMC1142062          DOI: 10.1136/jcp.42.8.840

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  31 in total

1.  Prevention of primary liver cancer. Report on a meeting of a W.H.O. Scientific Group.

Authors: 
Journal:  Lancet       Date:  1983-02-26       Impact factor: 79.321

2.  A potent inhibitor of Taq polymerase copurifies with human genomic DNA.

Authors:  R de Franchis; N C Cross; N S Foulkes; T M Cox
Journal:  Nucleic Acids Res       Date:  1988-11-11       Impact factor: 16.971

3.  The nucleotide sequence of the human beta-globin gene.

Authors:  R M Lawn; A Efstratiadis; C O'Connell; T Maniatis
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

4.  Expression of the hepatitis B virus surface, core and E antigen genes by stable rat and mouse cell lines.

Authors:  N M Gough; K Murray
Journal:  J Mol Biol       Date:  1982-11-25       Impact factor: 5.469

5.  Hepatitis B viral nucleotide sequences in non-A, non-B or hepatitis B virus-related chronic liver disease.

Authors:  A Figus; H E Blum; G N Vyas; S De Virgilis; A Cao; M Lippi; E Lai; A Balestrieri
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

6.  Integration of hepatitis B virus sequences and their expression in a human hepatoma cell.

Authors:  J C Edman; P Gray; P Valenzuela; L B Rall; W J Rutter
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

7.  Failure to detect nucleic acid homology between some non-A, non-B viruses and hepatitis B virus DNA.

Authors:  M J Fowler; J Monjardino; I V Weller; M Bamber; P Karayiannis; A J Zuckerman; H C Thomas
Journal:  J Med Virol       Date:  1983       Impact factor: 2.327

8.  Establishment of a continuously growing cell line from primary carcinoma of the liver.

Authors:  J J Alexander; E M Bey; E W Geddes; G Lecatsas
Journal:  S Afr Med J       Date:  1976-12-18

9.  The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw.

Authors:  Y Ono; H Onda; R Sasada; K Igarashi; Y Sugino; K Nishioka
Journal:  Nucleic Acids Res       Date:  1983-03-25       Impact factor: 16.971

10.  Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas.

Authors:  D A Shafritz; M C Kew
Journal:  Hepatology       Date:  1981 Jan-Feb       Impact factor: 17.425

View more
  24 in total

1.  Association of human beta-herpesviruses with the development of cervical cancer: bystanders or cofactors.

Authors:  P K Chan; M Y Chan; W W Li; D P Chan; J L Cheung; A F Cheng
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Short PCR product yields improved by lower denaturation temperatures.

Authors:  E P Yap; J O McGee
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

3.  Inhibitory effects of urine on the polymerase chain reaction for cytomegalovirus DNA.

Authors:  G Khan; H O Kangro; P J Coates; R B Heath
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

4.  Simplified procedures for applying the polymerase chain reaction to routinely fixed paraffin wax sections.

Authors:  P J Coates; A J d'Ardenne; G Khan; H O Kangro; G Slavin
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

5.  Heteroduplex formation as a means to exclude contamination in virus detection using PCR.

Authors:  Y M Lo; E S Lo; P Patel; C H Tse; K A Fleming
Journal:  Nucleic Acids Res       Date:  1991-12-11       Impact factor: 16.971

6.  Removal of inhibitor(s) of the polymerase chain reaction from formalin fixed, paraffin wax embedded tissues.

Authors:  S F An; K A Fleming
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

Review 7.  The molecular revolution--coming your way soon.

Authors:  P Quirke
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

8.  Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals.

Authors:  S A Ho; J A Hoyle; F A Lewis; A D Secker; D Cross; N P Mapstone; M F Dixon; J I Wyatt; D S Tompkins; G R Taylor
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

9.  Detection of human herpesviruses 6 and 7 genomic sequences in brain tumours.

Authors:  P K Chan; H K Ng; A F Cheng
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

10.  Geographical variation in prevalence of hepatitis B virus DNA in HBsAg negative patients.

Authors:  Y M Lo; E S Lo; W Z Mehal; M Sampietro; G Fiorelli; G Ronchi; C H Tse; K A Fleming
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.